Organization · Venture Capital
RYSE
RYSE is a London-based venture capital firm specializing in early-stage HealthTech investments, focusing on innovative solutions that enhance healthcare access, quality, and affordability.
Overview
What RYSE does
What RYSE is
RYSE is a London-based venture capital firm specializing in early-stage HealthTech investments, focusing on innovative solutions that enhance healthcare access, quality, and affordability.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find RYSE elsewhere
Open the official website or a supported primary organization account.
Capability profile
RYSE as a funder
Investment thesis
RYSE invests in early-stage HealthTech companies to improve healthcare access, quality, affordability, and delivery, particularly in underserved areas.
Focus narrative
RYSE specializes in investing in early-stage HealthTech companies, typically at the Seed and Series A stages. The firm targets sectors such as digital diagnostics, digital therapeutics, medical devices, and data and discovery platforms. Their investment thesis emphasizes addressing unmet clinical needs and improving access to healthcare.
Value beyond capital
RYSE adds value to its portfolio companies by providing not only capital but also access to distribution partnerships with health systems, accelerators, pharma, medtech, and clinicians. This support helps founders navigate the healthcare landscape and scale their innovations effectively.
Focus and fit
- Stages
- Seed · Series A · Friends and Family · Accelerator
- Sectors
- Healthcare · Digital Health · Digital Therapeutics · Medical Devices · Mental Health
- Regions
- Global · Europe · North America · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
Braingaze: Develops eye-tracking technology for early detection of neurodevelopmental and mental health disorders. Curio: Provides digital therapeutics focused on women's health, particularly postpartum depression. Ten63 Therapeutics: Works on developing therapeutics for cancer and other severe diseases. Second Nature: Offers an app that uses behavioral science to assist with weight loss. Skin Analytics: Specializes in AI-driven cancer screening for melanoma and non-melanoma skin cancers. Knokcare: A telemedicine solution for virtual consultations. Log My Care: Care management software designed for improved coordination in social care. MediShout: Provides healthcare reporting software to enhance quality and reduce costs. Oto: Develops digital therapeutics for tinnitus management.
Common questions
What to know about RYSE
Upseed classifies RYSE under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.